JointStart Original
Natural health product licensed in Canada
- Licence holder
- NutriStart Vitamin Company Inc.
- NPN or DIN-HM
- 80031677
- Status
- Active licence
- Licence date
- 24 April 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Exoskeleton of shrimp, prawn, crab and lobster stabilized with potassium chloride | 83 mg | Not calculated |
| Medicago sativa Source : Sommité Extraction ratio : 33:1 Dry plant equivalent : 2,739 mg | 83 mg | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Exosquelette de crabe | 83 mg | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : exosquelettes de homards | 83 mg | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Exosquelette de crevette (KCl) | 83 mg | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : exosquelettes de crevettes | 83 mg | Not calculated |
Non-medicinal ingredients
Microcrystalline cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | maximum: 3 Capsule | maximum: 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Methylsulfonlymethane (MSM) helps to relieve joint pain associated with osteoarthritis. Methylsulfonlymethane (MSM) helps to relieve the pain associated with osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80031677
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.